You are here

Press Releases

Medical Device Manufacturers Raise Public Health Concerns Over EPA Ethylene Oxide Value
Press Release | February 12, 2020
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) this week urged the U.S. EPA to reassess its risk assessment value for ethylene oxide (EtO), arguing the threshold is neither practical nor is it based on the latest science,... Read More
AdvaMed Drives MedTech Industry Inclusion and Diversity Efforts: “MedTech Leaders Must be as Diverse as the Patients They Serve”
Press Release | February 11, 2020
WASHINGTON, D.C. – This week, AdvaMed President and CEO, Scott Whitaker, and AdvaMed CFO and Executive Director of AdvaMed Advance, Jennifer Brearey, co-authored an editorial outlining steps the medical technology industry is taking to cultivate... Read More
AdvaMed and Biocom to Strategically Partner for The Digital MedTech Conference 2020
Press Release | February 10, 2020
WASHINGTON and SAN DIEGO – February 10, 2020 – The Advanced Medical Technology Association (AdvaMed) and Biocom, the association representing the California life science industry, today announced a joint partnership to collaboratively produce The... Read More
AdvaMed: USMCA a “Strong Step Forward” for MedTech, Patients
Press Release | January 29, 2020
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) issued the following statement from President and CEO Scott Whitaker on the signing into law of the United States-Mexico-Canada Agreement (USMCA) by President Trump: “The USMCA... Read More
AdvaMed Working Closely with U.S., Chinese Governments on Coronavirus Response, Readiness
Press Release | January 28, 2020
WASHINGTON, D.C. – Scott Whitaker, President and CEO of the Advanced Medical Technology Association (AdvaMed), issued the following statement on the emergence of the coronavirus: “As the leading global association for the medical technology industry... Read More
AdvaMed's Scott Whitaker Signs CEO Action for Diversity and Inclusion Pledge
Press Release | January 8, 2020
AdvaMed's Scott Whitaker Signs CEO Action for Diversity and Inclusion Pledge"We believe the medical technology industry should be an industry of choice for people of all backgrounds." Pictured Left to Right: Kevin Lobo, Scott Whitaker, Jennifer... Read More
With President Trump’s Signature, “Medical Device Tax Is Officially History”
Press Release | December 20, 2019
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) issued the following statement from President and CEO Scott Whitaker on President Trump's signing of legislation to repeal the medical device excise tax:   “This is a great day... Read More
LAB Act Passage a Critical Step Forward for Diagnostic Sector of Medtech Industry
Press Release | December 19, 2019
WASHINGTON, D.C. – AdvaMed President and CEO Scott Whitaker and AdvaMedDx Executive Director Susan Van Meter issued the following statements upon congressional passage of the Laboratory Access for Beneficiaries (LAB) Act as part of the broader... Read More
With Senate Passage of Device Tax Repeal, “Patients Are the Real Winners Here Today”
Press Release | December 19, 2019
WASHINGTON, D.C. – AdvaMed President and CEO Scott Whitaker today released the following statement on Senate passage of full repeal of the medical device excise tax: “On behalf of the entire medtech industry and the patients we serve, we thank the... Read More
House Vote to Repeal Medical Device Tax “a Huge Win” for American Patients
Press Release | December 17, 2019
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) issued the following statement from President and CEO Scott Whitaker on the U.S. House of Representatives’ vote to repeal the medical device excise tax:   “The House vote to... Read More

Pages